Neurodegeneration, an progressive decline in the health of neurons, presents a significant challenge to modern medicine. While there is currently no cure for neurodegenerative diseases, researchers are actively exploring innovative therapeutic approaches. One such direction of research involves deschloroketamine, a modified form of the anesthetic k